CardioComm Solutions, Inc
CardioComm Press Releases
 
  Previous Page previous page
About CardioComm
 

Letter from the CEO, July 9, 2013

Dear Shareholders and Friends:

In opening this CEO update, I acknowledge that shareholders and interested parties wish to have news about HeartCheckTM PEN sales, SMART Monitoring based revenue and the progress made with distribution agreements. I have stated that we have interest from North American and international distributors and this continues to hold true. We are now currently working with 22 different distribution groups, all of whom have ordered and paid for evaluation units of the HeartCheckTM devices with SMART Monitoring access rights.

There is an update to make on the distributor agreement to sell HeartCheckTM devices into the Gulf region with Waisco Medical and Scientific Solutions’. We have been in discussions with this company’s senior management regarding the length of time that has passed without sales. Waisco continues to confirm their obligations under the contract and have requested additional time to meet their performance milestones. Meanwhile, we are now working to sign additional (multi) distribution opportunities within the region.

Discussions are underway with organizations to set up pharmacy-based sales channels. Associated with this, we are expanding infrastructure to support our SMART Monitoring services overseas and this will include multi-language GEMS Home releases. We also will report on the use of the HeartCheckTM PEN, HeartCheckTM ECG handheld monitor and our patent pending SMART Monitoring technologies in clinical research studies – one such report is scheduled to be disclosed at the Canadian Cardiovascular Society meeting to be held in Montréal, Canada in the  fall.

Each time an update is prepared it is challenging to make it comprehensive enough to address issues of interest such as capitalization of the Company, social media marketing, pharmacy-based distribution models, new device integration for Bluetooth connectivity to smart phones and development of call service models with the HeartCheckTM products and patent pending SMART Monitoring service. What I can tell you is that each of these aforementioned topics are actively being managed and we may well be able to report on each of them separately in press releases within the remaining 2013 calendar year.

In closing, I thank those shareholders and HeartCheckTM PEN customers who have been emailing and calling me with their support and continued interest in CardioComm Solutions and the HeartCheckTM PEN.  Your personal experiences continue to demonstrate that we are on the right path in offering innovative solutions in personalized health management. In regards to inquiries about the company, we hear you. What I can say is the Company is doing well and we continue to look forward to making announcements which will demonstrate CardioComm Solutions’ unique position in the medical ECG management and consumer ECG monitoring markets. This is a company that will make a positive difference in many lives.

On behalf of the staff of CardioComm Solutions, we wish you all a safe and relaxing summer.

Sincerely,

Etienne Grima


Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.







Investor Information
 

December 11, 2012
November was a quiet month with respect to press releases from CardioComm Solutions (CCS); however, we’ve been very busy behind the scenes developing new channels for the promotion of our devices and software.


November 23, 2012
CardioComm Solutions, Inc. is pleased to confirm their participation in a BTV news release


November 1, 2012
The past few weeks have been very busy for CardioComm Solutions.


September 25, 2012
2012 North American Award for Enabling Technology for Cardiac Monitoring Technology


August 30, 2012
Heart and Stroke Foundation's Atrial Fibrillation screening booth set up at the Canadian National Exhibition


August 28, 2012
Invitations for HeartCheck™
PEN Device & Smart Monitoring Product Evaluation Starts this Week.



July 31, 2012
We are pleased to provide a preview of the new HeartCheck™ PEN product brochure that is now available on our website



June 27 2012
About WAISCO Inc from Medical
Coaches Incorporated




June 20 2012
"It’s been a busy two months for CardioComm Solutions, Inc."




April 30 2012
"CardioComm receives excellent initial response from Hospimedica International Advertising Campaign"



April 27 2012

CardioComm attends the World Congress of Cardiology Scientific Sessions in Dubai



May 8 2012

CardioComm Solutions Schedules Annual General Meeting (AGM) for June 27th, 2012



June 3 2013
Letter from the CEO


 


Investor Information


Etienne Grima
- MSc CHE
Chief Executive Officer

Anatoly Langer
MD, M.Sc, FRCPC, FACC
Chairman of the Board

William E. Smith
Board Member

Yury Levin

Board Member

David Newman
Board Member

Simi Grosman - MBA

Consultant & Board Member

Investor Information


Etienne Grima - MSc CHE
Chief Executive Officer

Wendy Hsieh
Chief Financial Officer

Wade Barnes
Chief Technology Officer


View more

 

Arrhythmia EKG Management | 12 Lead ECG Management | ECG Software | EKG Management | Web Based ECG | EKG Software